Почетна › Dijabetes tipa 2 › Kalifornija
Kliničke studije za Dijabetes tipa 2 u državi Kalifornija
74 studija za Dijabetes tipa 2 traži učesnike na lokacijama u državi Kalifornija.
Gradovi u državi Kalifornija
- San Diego21 студија
- Los Angeles18 студија
- Concord10 студија
- Sacramento10 студија
- Long Beach10 студија
- El Cajon9 студија
- Mountain View8 студија
- Santa Clarita8 студија
- Simi Valley8 студија
- Escondido7 студија
- Pomona6 студија
- Roseville5 студија
- Chula Vista5 студија
- Westminster5 студија
- Torrance4 студија
- San Francisco4 студија
- Huntington Beach4 студија
- Glendale4 студија
- Santa Monica4 студија
- San Bernardino4 студија
- West Covina4 студија
- Ontario4 студија
- Lancaster4 студија
- Lake Forest3 студија
- Santa Barbara3 студија
- South Gate3 студија
- Tustin3 студија
- Carson3 студија
Zvanični tekst studije (na engleskom)
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
- ProSciento, Chula Vista
- Headlands Research California LLC, Escondido
- Stanford University, Palo Alto
- и још 4
Тражи се учесник
Узраст од 2 до 80 · Оба пола · Ажурирано 13. 11. 2026. · NCT07864168A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
- Community Cancer Institute (CCI), Clovis
- The Lundquist Institute for BioMedical Innovation at Harbor-UCLA Medical Cente, Torrance
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07748208A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- San Fernando Valley Health, Canoga Park
- John Muir Physician Network Clinical Research Center, Concord
- Neighborhood Healthcare - Escondido, Escondido
- и још 10
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 13. 11. 2026. · NCT07754461A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes
- Orange County Research Center, Lake Forest
- Prospective Research Innovations Inc., Rancho Cucamonga
- Encompass Clinical Research, Spring Valley
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07112872EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- National Heart Institute, Beverly Hills
- Hope Clinical Research, Canoga Park
- John Muir Physician Network Clinical Research Center, Concord
- и још 11
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT07064473A Study to Investigate Safety, Tolerability, PK, and PD of AZD4248 in Healthy Participants, Participants With CKD and Type 2 Diabetes, Assess Home Measurements of Creatinine in a Non-Interventional Cohort, and Assess the Effect of AZD4248 on the PK of Midazolam and Metformin in Healthy Participants
- Research Site, Glendale
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 75 · Оба пола · Ажурирано 12. 11. 2026. · NCT07024823Food Insecurity Reduction & Strategy Team
- Stanford Medicine, Palo Alto
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT06329375Continuous Glucose Monitoring for Self-Management of Type 2 Diabetes in Young Adults
- Scripps Health, San Diego
Тражи се учесник
Узраст од 18 до 45 · Оба пола · Ажурирано 9. 11. 2026. · NCT07065721A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Escondido
- Research Site, Lincoln
- Research Site, Walnut Creek
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07776509A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- University of California Irvine, Irvine
- Orange County Research Center, Lake Forest
- Ark Clinical Research, Long Beach
- и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Sutter Valley Medical Foundation (SVMF) Pediatric Endocrinology, Sacramento
- Rady Children's Hospital, San Diego
Тражи се учесникФаза 3
Узраст од 10 до 17 · Оба пола · Ажурирано 5. 11. 2026. · NCT07668336Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes
- Acclaim Clinical Research, San Diego
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07866066A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
- Institute for Metabolic Research Los Angeles, Los Angeles
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07843485A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- San Fernando Valley Health Institute, Canoga Park
- Headlands Research California, LLC, Escondido
- ImmuniMet, LLC, Modesto
- и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
- Pacific Clinical Studies Inc., Los Alamitos
- Los Angeles Institute for Metabolic Research, Los Angeles
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07881458A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- San Fernando Valley Health Institute, Canoga Park
- AMCR Institute, Escondido
- NorCal Medical Research, Inc, Greenbrae
- и још 6
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Wolverine Clinical Trials, Santa Ana
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT06897475A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Thrive Clinical Research Group, Glendora
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT07783802A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Bakersfield
- Research Site, Los Angeles
- Research Site, Ontario
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07662109A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Bakersfield
- Research Site, Gardena
- Research Site, Lincoln
- и још 2
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- AME Clinical Research, Huntington Beach
- Amicis Research Center, Northridge
- FOMAT - Vista del Mar Medical Group, Oxnard
- и још 5
Тражи се учесникФаза 2
Узраст од 18 до 80 · Оба пола · Ажурирано 27. 10. 2026. · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Covina
- Research Site, Encinitas
- Research Site, Garden Grove
- и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 22. 10. 2026. · NCT07662213New T-UP: Engaging Vulnerable Students in Diabetes Prevention
- University of California, Los Angeles, Los Angeles
Тражи се учесник
Узраст од 17 до 25 · Оба пола · Ажурирано 21. 10. 2026. · NCT07225218Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy
- Hope Clinical Research, Canoga Park
- Ark Clinical Research, Long Beach
- Catalina Research Institute, LLC, Montclair
- и још 1
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 20. 10. 2026. · NCT07502508Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
- Care Access Research - Santa Clarita, Santa Clarita
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 19. 10. 2026. · NCT07527650A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication
- PAREXEL Glendale/LA EPCU, Glendale
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT07868354A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication
- PAREXEL Glendale/LA EPCU, Glendale
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT07855133KPSC MNT Pilot RCT
- Kaiser Permanente San Bernardino County Medical Center, Fontana
Тражи се учесник
Узраст од 18 до 75 · Оба пола · Ажурирано 9. 10. 2026. · NCT07868250A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes
- Ark Clinical Research, Fountain Valley
- Ark Clinical Research, Long Beach
- Los Angeles Institute for Metabolic Research, Los Angeles
- и још 1
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT07668388Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Ark Clinical Research - Fountain Valley, Fountain Valley
- Velocity Clinical Research, Huntington Park, Huntington Park
- Velocity Clinical Research - Gardena, La Mesa
- и још 5
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 6. 10. 2026. · NCT07296484Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- San Fernando Valley Health Institute, Canoga Park
- Core Healthcare Group, Cerritos
- Velocity Clinical Research Chula Vista, La Mesa
- и још 2
Тражи се учесникФаза 3
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684144Efficacy of Using Mobile Health Applications for Health
- San Diego State University, San Diego
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 64 · Оба пола · Ажурирано 2. 10. 2026. · NCT05589155Efficacy of mHealth Apps for Health in a Low-income, Type II Diabetic, Hispanic Population
- San Diego State University, San Diego
Тражи се учесникЗдраве особе су добродошле
Узраст од 18 до 64 · Оба пола · Ажурирано 2. 10. 2026. · NCT05279729Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
- Ark Clinical Research, Fountain Valley
- Thrive Clinical Research Group, Glendora
- Scripps Whittier Diabetes Inst, La Jolla
- и још 5
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 30. 9. 2026. · NCT07817251A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Cardiovascular Research Foundation of Southern California, Beverly Hills
- Amicis Research: Beverly Hills, Beverly Hills
- Valiance Clinical Research - Canoga Park, Canoga Park
- и још 21
Тражи се учесникЗдраве особе су добродошле
Узраст 55 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06112418Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes
- Stanford University, Stanford
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT06836479A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Banning
- AURORA-2 Clinical Site, Chula Vista
- AURORA-2 Clinical Site, Covina
- и још 6
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
- Research Site, Glendale
Тражи се учесникФаза 1Здраве особе су добродошле
Узраст од 18 до 55 · Оба пола · Ажурирано 16. 9. 2026. · NCT07723833Pregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes
- UC Davis Medical Center, Sacramento
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст 18 и старији · Оба пола · Ажурирано 14. 9. 2026. · NCT07176793A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 Diabetes
- First Valley Medical Group, Lancaster
- Torrance Clinical Research Institute, Inc., Lomita
- Ark Clinical Research, Long Beach
- и још 3
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 11. 9. 2026. · NCT07415954Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.